Global Bioprocess Containers market data 2024, Forecast To 2033

25 Jan, 2024

The bioprocess containers market has witnessed exponential growth, escalating from $4.15 billion in 2023 to $5.24 billion in 2024, with a compound annual growth rate (CAGR) of 26.2%. The growth in the historic period is attributed to the expansion of the biopharmaceutical industry, government investments in research and development, the increase in the privatization of laboratory services, and a rise in healthcare spending. Foreseeing exponential growth, the market is projected to reach $13.72 billion in 2028, maintaining a remarkable CAGR of 27.2%. The forecasted growth is driven by rising healthcare investments, expanding markets in emerging economies, regulatory support, and an increase in disposable income. Major trends in the forecast period include sustainability solutions, digitalization and data analytics, outsourcing and contract manufacturing, customization with modular systems, and a focus on personalized medicine and patient-centric manufacturing.

Global Bioprocess Containers Market Key Driver

The bioprocess containers market is thriving due to increased biopharmaceutical R&D activities. IQVIA's report in February 2022 highlights a 68% surge in global biopharmaceutical products under development since 2016. As R&D continues to flourish, the demand for bioprocess containers is set to escalate, sustaining growth in 2023, 2024, and 2028.

Get A Free Sample Of The Global Bioprocess Containers Market Report

Global Bioprocess Containers Market Segments

The global bioprocess containers market covered in this report is segmented –
1) By Type: 2D Bioprocess Containers, 3D Bioprocess Containers, Tank Liners, Other Containers & Accessories
2) By Application: Process Development, Upstream, Downstream
3) By End User: Biopharmaceutical Companies, Life Science R&D Companies, Other End Users
By Geography: The regions covered in the Bioprocess Containers market report are Asia-Pacific, Western Europe, Eastern Europe,North America, South America, Middle East, and Africa.

Major Bioprocess Containers Industry Players

Sartorius Stedim Biotech S.A., Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Sartorius AG, Compagnie de Saint-Gobain S.A., Lonza Group AG, Avantor Inc., Eppendorf AG, Meissner Filtration Products Inc., Corning Incorporated, GE Healthcare Technologies Inc., Fluids Control Inc., Neta Scientific Incorporated, ALLpaQ Packaging Group plc, Kawasumi Laboratories Inc., F.L. Medical SRL, Sani-Tech West Inc., Cellon SA, Celltainer Biotech BV, Entegris Inc., Flexboy AG, GE Healthcare Life Sciences, GEA Group AG, GEMÜ Group, GVS Group Ltd., Integra Companies, Kuhner AG, L.B. Bohle Maschinen + Verfahren GmbH, Raith GmbH

Get The Full Global Bioprocess Containers Market Report

Bioprocess Containers Market Overview

Bioprocess containers are single-use containers that are used for critical sterile liquid-handling applications in the biopharmaceutical industry. It is used for liquid cell culture media, reagents, buffers, containment, and storage vessels for intermediate and final products yielded from manufacturing processes.

Bioprocess Containers Global Market Report 2023 provides data on the global bioprocess containers market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The bioprocess containers market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.